ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01009593
Recruitment Status : Terminated (See termination reason in detailed description)
First Posted : November 6, 2009
Last Update Posted : September 10, 2012
Sponsor:
Information provided by (Responsible Party):
Abbott

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : July 2012